Loading chart...
ABBVABBV
$264.02In rialzo 0.58 percento, +$1.51
Il Sep 17 alle 4:00 PM ET
Statistiche chiave
Capitalizzazione di Mercato$463.886B
Volume (24h)1,815,713
Day's Range$260.93-$264.57
52-Week Range$190.75-$267.47
PE Ratio129.42
EPS2.04
Net Income (FY)$4.23B
Revenue (FY)$61.16B
Chi Siamo ABBVIE INC.
AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics, including Botox. The 2024 acquisitions of Cerevel (neuroscience) and ImmunoGen (oncology) help supplement AbbVie's portfolio.
- Sito web
- abbvie.com
- Settore
- PHARMACEUTICAL PREPARATIONS
- Dipendenti a tempo pieno
- 57.000
- Sede
- NORTH CHICAGO
- Data IPO
- Dec 10, 2012
| 24 ore | 5 days | 1 mese | YTD | 1 anno | Sempre |
|---|---|---|---|---|---|
In rialzo 0.58 percento | In rialzo 2.68 percento | In rialzo 5.47 percento | In rialzo 14.92 percento | In rialzo 19.57 percento | In rialzo 651.77 percento |
